Low Remifentanil Target Controlled Infusions for Cardiac Surgery
Status:
Completed
Trial end date:
2019-05-15
Target enrollment:
Participant gender:
Summary
The development of target effect-site controlled concentrations (TCI) of remifentanil have
gained increasing acceptance during cardiac surgery as regarding the resulting of hemodynamic
stability and early extubation. The use of low-dose opioid technique has been progressively
used nowadays because of its ceiling effect to attenuate cardiovascular responses to noxious
stimuli. We hypothesize that the use of low target remifentanil effect site concentrations
may provide comparable shorter times to tracheal extubation and hemodynamic stability to the
use of high remifentanil Ce during target-controlled propofol anesthesia for cardiac surgery.